ArticleOTA international : the open access journal of orthopaedic trauma2026
Continuous local antibiotic perfusion therapy: a prophylactic strategy for Gustilo-Anderson type III open fractures.
Article in OTA international : the open access journal of orthopaedic trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Managing Gustilo-Anderson type III open fractures remains a challenge in orthopaedic trauma. Continuous local antibiotic perfusion (CLAP) therapy serves as a potential adjunct for infection prevention. In this study, the authors evaluated the clinical outcomes in patients with Gustilo-Anderson type III open fractures treated using an orthoplastic approach with CLAP therapy. Design: Single-center retrospective review. Setting: Tertiary trauma and reconstruction center (2020-2023). Patients/Participants: Twenty-two patients (mean age, 54.8 years) with Gustilo-Anderson type III open fractures of the extremities were included. Intervention: All patients received CLAP therapy with gentamicin as an adjunct to systemic antibiotics, staged fixation, and orthoplastic soft tissue management. Main Outcome Measurements: Data included demographics, injury and hospitalization details, type of fixation and coverage, CLAP therapy dosage, union rate, time-to-union, and CLAP therapy-related complications. Results: Two patients (9%) developed infections within 9 months. Primary union was achieved in 20 patients (91%); the remaining 2 achieved union after secondary bone grafting (overall 100%). The mean time-to-union was 6.4 months, and the mean follow-up duration was 21.5 months. No systemic adverse effects attributable to CLAP therapy were observed. Conclusions: CLAP therapy, as an adjunct to intravenous antibiotics, debridement, soft tissue reconstruction, and staged fixation, resulted in a relatively low infection rate (9%) in a small (22 patients) series of Gustilo-Anderson type III open fractures and was associated with a high union rate (91% primary, 100% with secondary surgery) and no recognized complications directly attributable to CLAP therapy. However, the absence of a control group precludes conclusions regarding comparative effectiveness. Level of Evidence: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.